The FDA has issued a significant recall of duloxetine capsules over contamination fears, leaving patients and healthcare providers in cautious anticipation of viable alternatives. Over 7000 bottles have been recalled. Alternative medicines are being deployed. Recall Overview The U.S. Food and Drug Administration (FDA) has recalled 7,107 bottles of duloxetine delayed-release capsules, sold under the brand name Cymbalta, due to the finding of N-nitroso-duloxetine. This chemical is a probable carcinogen, raising the risk of cancer if consumed in significant amounts. These 20mg capsules, identified by lot number 220128 with an expiration date of December 2024, were mainly supplied by Towa Pharmaceutical Europe. N-nitroso-duloxetine is known for its potential carcinogenic effects, particularly when found in higher concentrations than the recommended safety thresholds for daily intake. This recall falls into the Class II category, indicating limited health consequences but necessary precautionary measures. Breckenridge Pharmaceutical, the principal distributor, has emphasized this classification indicates a minimal risk of significant health problems for consumers. Duloxetine Recall: FDA Flags Carcinogenic Risk for Popular Antidepressant https://t.co/kyhHo5Q8b8 via @peoplespharmacy — The Peoples Pharmacy (@PeoplesPharmacy) October 27, 2024 Guidelines for Healthcare Providers The FDA advises medical professionals to discuss alternative treatment options with affected patients. Pharmacists should confirm if the medications being dispensed are part of the recall and consider offering lots that are not involved in the recall. The integrity of this medication is crucial as it treats patients suffering from depression, anxiety, and mood disorders, hence the importance of sustainable alternatives. “FDA, in collaboration with regulatory counterparts around the world, has set internationally-recognized acceptable daily intake limits for nitrosamines. Nitrosamines below this level are acceptable in drugs. If drugs contain levels of nitrosamines above the acceptable daily intake limit, FDA recommends these drugs be recalled by the manufacturer.” – FDA Since nitrosamine impurities have prompted several recalls, particularly in medications such as anticoagulants and metformin, healthcare professionals have become vigilant about conducting detailed assessments of compromised drug products. Hence, there is an emphasis on patient education and counseling to ensure safety while preserving mental health stability. The FDA has announced a recall for thousands of bottles of the antidepressant duloxetine, sold under brand names like Cymbalta, due to the presence of a chemical that can potentially cause cancer. https://t.co/XeKh5pfZI0 — TODAY (@TODAYshow) October 26, 2024 Historical Context and Safety Measures Recalls for nitrosamine impurities are not unprecedented. Concerns with these elements often stem from production and storage conditions, leading to heightened scrutiny in drug manufacturing processes. The FDA continues to guide manufacturers towards more stringent quality control to prevent such chemical contaminations, promoting consumer safety and trust. “Nitrosamine impurities may increase the risk of cancer if people are exposed to them above acceptable levels and over long periods of time, but a person taking a drug that contains nitrosamines at-or-below the acceptable daily intake limits every day for 70 years is not expected to have an increased risk of cancer.” Sources: Cymbalta recall. Cymbalta cancer concern. The post Duloxetine Capsules Pulled: FDA Raises Alarming Health Safety Warning appeared first on The Conservative Brief.

Ilona Maher is a hero on and off the field. The Olympian turned Dancing With The Stars stand-out dancer shared a scary story time on TikTok about a recent nail salon trip. Ilona explained she went to get a pedicure near closing time at a nail salon and was one of the last customers. She was in the salon with two women when a man came for a pedicure. At first, Ilona Maher didn’t think much of it, but after a while, the DWTS contestant realized she’d been sitting there a long time. @ilonamaher Please be safe out there. ♬ original sound – Ilona Maher Ilona Maher Shared The Cautionary Tale With Her “DWTS” Fans Even though she thought her nails were dry and she was ready to go, the employees encouraged her to stay. She explained in her TikTok, “I wait there for, no joke, an extra half hour.” The man finally left, and the woman confessed to Ilona they were afraid to be left alone. “And then they said, ‘Sorry we kept you so long, we just wanted you to be here with us while he was there,'” Ilona explained. “And I was like, I totally understood then why they did that.” Ilona Maher fans who follow her Olympic career or her skills on DWTS know she is tall and very strong. Her physique isn’t lost on her, and she told TikTok that she has their backs. “And I want you to know you can keep me for as long as you want, you can keep me for another hour, I’ll cancel my plans if you want me for safety or you want somebody there just to be a presence. It’s dangerous out there.”  Ilona ended her video quickly, “Seriously, stay safe ladies.” “THIS! Is the definition of a girls girl,” a fan wrote. This person agreed and would love to befriend the DWTS contestant, “The way I would feel SO SAFE walking through a dark parking lot with Ilona Maher.” Ilona, you are amazing. Thank you for just being you! This story’s featured image can be found here. The post “DWTS” Dancer & Olympian Ilona Maher Shares How She Protected Two Women From Terrifying Man “It’s A Crazy World” appeared first on InspireMore.

The farm was raided by the Pennsylvania Department of Agriculture, not the federal government

'You have a reporter who seems to be playing tee ball'

'We need more than platitudes'

'it's such a question mark right now'

Harris could lose to former President Donald Trump

We reportedly have some drama poppin' off in the SEC

The paper decided not to make a presidential endorsement

He left a long legacy of iconic films behind